For years, AIDS patients have depended on a cocktail of drugs to treat their condition. Now researchers for Gilead Sciences and Bristol-Myers Squibb say they're close to gaining approval for a single-dose, daily AIDS drug that can replace the cocktail of medicines that have been used to fight the disease. Later this year the as-yet unnamed pill will be submitted for approval to the FDA. It will contain three drugs currently available to treat AIDS patients.
- read this article from The Washington Post for more information